BBIO
BridgeBio Pharma Inc.
Latest News for BBIO
Bridgebio Pharma (($BBIO)) has held its Q3 earnings call. Read on for the main highlights of the call. BridgeBio Pharma’s recent earnings call refl......
In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on BridgeBio Pharma, with a price target of $98.00. The company’s......
Bridgebio Pharma ( ($BBIO) ) has released its Q3 earnings. Here is a breakdown of the information Bridgebio Pharma presented to its investors. Brid......
The latest announcement is out from BridgeBio Pharma ( ($BBIO) ). BridgeBio Pharma announced positive results from its Phase 3 CALIBRATE study of e......
Evercore ISI analyst Cory Kasimov maintained a Buy rating on BridgeBio Pharma today and set a price target of $75.00. The company’s shares opened t......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Urogen Pharma (URGN – Research Report), AngioDynamic......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $68.11 | +5.4% | 4.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |